A prospective observational study to evaluate the clinical outcomes and burden of disease of PD patients with motor fluctuations not adequately controlled by current PD medications (PROSPECT)

29/09/2020
14/03/2024
EU PAS number:
EUPAS36303
Study
Ongoing
Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Prospective observational study
Study drug and medical condition

Medical condition to be studied

Parkinson's disease
Population studied

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

550
Study design details

Main study objective

The objective of this observational study is to describe the clinical outcomes and disease burden of advancing PD disease in PD patients with motor fluctuations no longer controlled by current PD medications.

Outcomes

Change of Off time from baseline to 24 months as measured by PD diary. Change in Off time from baseline to 12 monthsChange in dyskinesia from baseline to 12 and 24 monthsChange in HY Stage (in ON and OFF state) from baseline to 12 and 24 monthsChange in EQ5D5L patient and caregiver Total score from baseline to 12 and 24 monthsChange in MDS UPDRS part II score from baseline to 12 and 24 monthsChange in NMSS Total score from baseline to 12 and 24 months

Data analysis plan

Descriptive statistics will be used to summarize all endpoints. Continuous endpoints will be summarized using number of missing and non-missing observations, mean, median, minimum, maximum, standard deviation and 95% confidence interval. Categorical values will be summarized as the number of patients and percentages (%) of patients in each category.